DROSPIRENONE AND EHTINYL ESTRADIOL

Drospirenone And Ehtinyl Estradiol Adverse Events Reported to the FDA Over Time

How are Drospirenone And Ehtinyl Estradiol adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Drospirenone And Ehtinyl Estradiol, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Drospirenone And Ehtinyl Estradiol is flagged as the suspect drug causing the adverse event.

Most Common Drospirenone And Ehtinyl Estradiol Adverse Events Reported to the FDA

What are the most common Drospirenone And Ehtinyl Estradiol adverse events reported to the FDA?

Gallbladder Disorder	77 (11.24%)
Pulmonary Embolism	52 (7.59%)
Deep Vein Thrombosis	40 (5.84%)
Cholecystectomy	29 (4.23%)
Cholelithiasis	28 (4.09%)
Abdominal Pain	26 (3.8%)
Pain	24 (3.5%)
Nausea	21 (3.07%)
Gallbladder Injury	20 (2.92%)
Vomiting	19 (2.77%)
Abdominal Pain Upper	15 (2.19%)
	Show More
Cerebrovascular Accident	13 (1.9%)
Cholecystitis Chronic	13 (1.9%)
Dyspnoea	11 (1.61%)
Injury	11 (1.61%)
Diarrhoea	10 (1.46%)
Thrombosis	9 (1.31%)
Chest Pain	8 (1.17%)
Headache	7 (1.02%)
Myocardial Infarction	7 (1.02%)
Depression	6 (.88%)
Gallbladder Cholesterolosis	6 (.88%)
Oedema Peripheral	6 (.88%)
Pain In Extremity	6 (.88%)
Dyspepsia	5 (.73%)
Syncope	5 (.73%)
Abdominal Discomfort	4 (.58%)
Abdominal Distension	4 (.58%)
Abdominal Pain Lower	4 (.58%)
Anxiety	4 (.58%)
Bile Duct Stone	4 (.58%)
Biliary Colic	4 (.58%)
Chest Discomfort	4 (.58%)
Dizziness	4 (.58%)
Emotional Distress	4 (.58%)
Gallbladder Non-functioning	4 (.58%)
Hepatic Function Abnormal	4 (.58%)
Jaundice	4 (.58%)
Transient Ischaemic Attack	4 (.58%)
Back Pain	3 (.44%)
Biliary Dyskinesia	3 (.44%)
Fear Of Death	3 (.44%)
Hyperhidrosis	3 (.44%)
Nervousness	3 (.44%)
Palpitations	3 (.44%)
Pancreatitis	3 (.44%)
Tachycardia	3 (.44%)
Abdominal Tenderness	2 (.29%)
Abortion Induced	2 (.29%)
Aphagia	2 (.29%)
Arrhythmia	2 (.29%)
Asthma	2 (.29%)
Blood Copper Decreased	2 (.29%)
Brain Herniation	2 (.29%)
Brain Oedema	2 (.29%)
Cardiac Arrest	2 (.29%)
Cholecystitis Acute	2 (.29%)
Diarrhoea Haemorrhagic	2 (.29%)
Drug Exposure During Pregnancy	2 (.29%)
Fatigue	2 (.29%)
Food Intolerance	2 (.29%)
Gastric Disorder	2 (.29%)
Gastric Ph Decreased	2 (.29%)
Gastritis	2 (.29%)
Gastrointestinal Disorder	2 (.29%)
Haematemesis	2 (.29%)
Haematochezia	2 (.29%)
Hepatic Enzyme Increased	2 (.29%)
Hydrocephalus	2 (.29%)
Hypertension	2 (.29%)
Hysterectomy	2 (.29%)
Intracranial Venous Sinus Thrombosi...	2 (.29%)
Liver Injury	2 (.29%)
Malaise	2 (.29%)
Meningomyelocele	2 (.29%)
Metrorrhagia	2 (.29%)
Nephrolithiasis	2 (.29%)
Neural Tube Defect	2 (.29%)
Neurological Decompensation	2 (.29%)
No Adverse Event	2 (.29%)
Normal Newborn	2 (.29%)
Skin Discolouration	2 (.29%)
Talipes	2 (.29%)
Urine Copper Decreased	2 (.29%)
Vertigo	2 (.29%)
Weight Decreased	2 (.29%)
White Blood Cell Count Increased	2 (.29%)
Abortion Spontaneous	1 (.15%)
Acne	1 (.15%)
Adverse Event	1 (.15%)
Affect Lability	1 (.15%)
Appendicitis Perforated	1 (.15%)
Asthenia	1 (.15%)
Brain Compression	1 (.15%)
Breast Tenderness	1 (.15%)
Cerebral Infarction	1 (.15%)
Cholecystitis	1 (.15%)
Complex Partial Seizures	1 (.15%)
Constipation	1 (.15%)
Convulsion	1 (.15%)
Dyspnoea Exertional	1 (.15%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Drospirenone And Ehtinyl Estradiol, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Drospirenone And Ehtinyl Estradiol is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Drospirenone And Ehtinyl Estradiol

What are the most common Drospirenone And Ehtinyl Estradiol adverse events reported to the FDA?

Gallbladder	134 (19.56%)
Gastrointestinal Signs	104 (15.18%)
Pulmonary Vascular	54 (7.88%)
Embolism And Thrombosis	53 (7.74%)
Injuries	33 (4.82%)
Hepatobiliary Therapeutic Procedure...	29 (4.23%)
Central Nervous System Vascular	21 (3.07%)
Respiratory	16 (2.34%)
Gastrointestinal Motility And Defec...	14 (2.04%)
Anxiety Disorders	12 (1.75%)
Hepatic And Hepatobiliary	12 (1.75%)
	Show More
Neurological	12 (1.75%)
Musculoskeletal And Connective Tiss...	9 (1.31%)
Bile Duct	8 (1.17%)
Cardiac Arrhythmias	8 (1.17%)
Headaches	8 (1.17%)
Coronary Artery	7 (1.02%)
Depressed Mood Disorders	6 (.88%)
Increased Intracranial Pressure And...	5 (.73%)
Menstrual Cycle And Uterine Bleedin...	5 (.73%)
Mood Disorders	5 (.73%)
Gastrointestinal Conditions	4 (.58%)
Gastrointestinal Hemorrhages	4 (.58%)
Neurological Disorders Congenital	4 (.58%)
Obstetric And Gynecological Therape...	4 (.58%)
Skin Appendage Conditions	4 (.58%)
Water, Electrolyte And Mineral	4 (.58%)
Cardiac Disorder Signs	3 (.44%)
Epidermal And Dermal Conditions	3 (.44%)
Exocrine Pancreas Conditions	3 (.44%)
Physical Examination Topics	3 (.44%)
Procedural And Device Related Injur...	3 (.44%)
Bronchial Disorders	2 (.29%)
Chemical Injury And Poisoning	2 (.29%)
Food Intolerance Syndromes	2 (.29%)
Gastrointestinal	2 (.29%)
Gastrointestinal Inflammatory Condi...	2 (.29%)
Hematology Investigations	2 (.29%)
Hepatobiliary	2 (.29%)
Infections - Pathogen Unspecified	2 (.29%)
Inner Ear And Viiith Cranial Nerve	2 (.29%)
Musculoskeletal And Connective Tiss...	2 (.29%)
Pregnancy, Labour, Delivery And Pos...	2 (.29%)
Seizures	2 (.29%)
Urolithiases	2 (.29%)
Vascular Hypertensive	2 (.29%)
Abortions And Stillbirth	1 (.15%)
Breast	1 (.15%)
Cardiac And Vascular Investigations	1 (.15%)
Endocrine Investigations	1 (.15%)
Movement Disorders	1 (.15%)
Nephropathies	1 (.15%)
Nervous System Neoplasms Benign	1 (.15%)
Psychiatric	1 (.15%)
Sexual Dysfunctions, Disturbances A...	1 (.15%)
Therapeutic And Nontherapeutic Effe...	1 (.15%)
Upper Respiratory Tract Disorders	1 (.15%)
Urinary Tract Signs	1 (.15%)
Vision	1 (.15%)
Vulvovaginal Disorders	1 (.15%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Drospirenone And Ehtinyl Estradiol, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Drospirenone And Ehtinyl Estradiol is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.